Treprostinil Iontophoresis Improves Digital Blood Flow during Local Cooling in Systemic Sclerosis

Microcirculation

Volumn 23, Issue 3, 2016, Pages 266-270

  Gaillard Bigot, Florence ^a,b,c   Roustit, Matthieu ^a,b,c   Blaise, Sophie ^b,c   Cracowski, Claire ^b,c   Seinturier, Christophe ^b   Imbert, Bernard ^b   Carpentier, Patrick ^b   Cracowski, Jean Luc ^a,b,c  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c University Grenoble Alpes   (France)

Author keywords

laser speckle contrast imaging; microcirculation; prostacyclin; Raynaud's phenomenon; systemic sclerosis

Indexed keywords

PLACEBO; TREPROSTINIL; PROSTACYCLIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CAPILLAROSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; COOLING; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; HAND COOLING; HUMAN; IMAGING AND DISPLAY; INFORMED CONSENT; IONTOPHORESIS; LASER SPECKLE CONTRAST IMAGING; SKIN BLOOD FLOW; SYSTEMIC SCLEROSIS; AGED; ANALOGS AND DERIVATIVES; BLOOD FLOW VELOCITY; CLINICAL TRIAL; DRUG EFFECTS; INDUCED HYPOTHERMIA; MALE; MICROCIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; SCLERODERMA, SYSTEMIC; SKIN; VASCULARIZATION;

AGED; BLOOD FLOW VELOCITY; EPOPROSTENOL; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; IONTOPHORESIS; MALE; MICROCIRCULATION; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN;

EID: 85011397566     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12272     Document Type: Article

References (23)

1. Hachulla E, Clerson P, Launay D, Lambert M, Morell-Dubois S, Queyrel V, Hatron PY. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol 34: 2423–2430, 2007.
2. Mihai C, Landewé R, van der Heijde D, Walker UA, Constantin PI, Gherghe AM, Ionescu R, Rednic S, Allanore Y, Avouac J, Czirják L, Hachulla E, Riemekasten G, Cozzi F, Airò P, Cutolo M, Mueller-Ladner U, Matucci-Cerinic M. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis 2015. pii: annrheumdis-2014-205897. [Epub ahead of print].
3. Mouthon L, Mestre-Stanislas C, Bérezné A, Rannou F, Guilpain P, Revel M, Pagnoux C, Guillevin L, Fermanian J, Poiraudeau S. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis 69: 214–217, 2010.
4. Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 68: 620–628, 2009.
5. Hachulla E, Hatron P-Y, Carpentier P, Agard C, Chatelus E, Jego P, Mouthon L, Queyrel V, Fauchais AL, Michon-Pasturel U, Jaussaud R, Mathian A, Granel B, Diot E, Farge-Bancel D, Mekinian A, Avouac J, Desmurs-Clavel H, Clerson P. Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study. Ann Rheum Dis 2015. pii: annrheumdis-2014-207001. [Epub ahead of print].
6. Blaise S, Roustit M, Millet C, Ribuot C, Boutonnat J, Cracowski JL. Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats. Br J Pharmacol 162: 557–565, 2011.
7. Kotzki S, Roustit M, Arnaud C, Godin-Ribuot D, Cracowski J-L. Effect of continuous vs pulsed iontophoresis of treprostinil on skin blood flow. Eur J Pharm Sci 72: 21–26, 2015.
8. Blaise S, Roustit M, Hellmann M, Millet C, Cracowski JL. Cathodal iontophoresis of treprostinil induces a sustained increase in cutaneous blood flux in healthy volunteers. J Clin Pharmacol 53: 58–66, 2013.
9. Roustit M, Gaillard-Bigot F, Blaise S, Stanke-Labesque F, Cracowski C, Seinturier C, Jourdil JF, Imbert B, Carpentier PH, Cracowski JL. Cutaneous iontophoresis of treprostinil in systemic sclerosis: a proof-of-concept study. Clin Pharmacol Ther 95: 439–445, 2014.
10. Hellmann M, Roustit M, Gaillard-Bigot F, Cracowski J-L. Cutaneous iontophoresis of treprostinil, a prostacyclin analog, increases microvascular blood flux in diabetic malleolus area. Eur J Pharmacol 758: 123–128, 2015.
11. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TAJr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, vanLaar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72: 1747–1755, 2013.
12. Roustit M, Millet C, Blaise S, Dufournet B, Cracowski JL. Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity. Microvasc Res 80: 505–511, 2010.
13. Little J, Murray A, Dinsdale G, Wilkinson J, Moore T, Herrick AL. Whole finger iontophoresis of sodium nitroprusside to increase blood flow in patients with systemic sclerosis: influence of concentration. Int J Pharm 490: 446–449, 2015.
14. Flavahan NA. A vascular mechanistic approach to understanding Raynaud phenomenon. Nat Rev Rheumatol 11: 146–158, 2015.
15. Fava A, Wung PK, Wigley FM, Hummers LK, Daya NR, Ghazarian SR, Boin F. Efficacy of rho-kinase inhibitor fasudil in secondary Raynaud's phenomenon. Arthritis Care Res 64: 925–929, 2012.
16. Herrick A, Murray A, Ruck A, Rouru J, Moore T, Whiteside J, Hakulinen P, Wigley F, Snapir A. A double-blind placebo-controlled crossover trial of the alpha-2C adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis. Arthritis Rheum 64: S636, 2012.
17. Roustit M, Hellmann M, Cracowski C, Blaise S, Cracowski JL. Sildenafil increases digital skin blood flow during all phases of local cooling in primary Raynaud's phenomenon. Clin Pharmacol Ther 91: 813–819, 2012.
18. Friedman EA, Harris PA, Wood AJ, Stein CM, Kurnik D. The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon. Clin Pharmacol Ther 81: 503–509, 2007.
19. Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, Hsu V, Rothfield N, Steen V, Martin RW, Smith E, Mayes M, Simms R, Pope J, Kahaleh B, Csuka ME, Gruber B, Collier D, Sweiss N, Gilbert A, Dechow FJ, Gregory J, Wigley FM. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. Arthritis Rheum 60: 870–877, 2009.
20. Hummers LK, Dugowson CE, Dechow FJ, Wise RA, Gregory J, Michalek J, Yenokyan G, McGready J, Wigley FM. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. Ann Rheum Dis 72: 1962–1967, 2013.
21. Ruaro B, Sulli A, Alessandri E, Pizzorni C, Ferrari G, Cutolo M. Laser speckle contrast analysis: a new method to evaluate peripheral blood perfusion in systemic sclerosis patients. Ann Rheum Dis 73: 1181–1185, 2014.
22. Ruaro B, Sulli A, Smith V, Paolino S, Pizzorni C, Cutolo M. Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients. Microvasc Res 101: 82–85, 2015.
23. Domsic RT, Dezfulian C, Shoushtari A, Ivanco D, Kenny E, Kwoh CK, Medsger TA Jr, Champion HC. Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients. Clin Exp Rheumatol 32: S-154–S-160, 2014.